Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v6-FR
Language English French
Date Updated 2019-06-07 2019-05-27
Drug Identification Number 02399024 02399024
Brand name BYSTOLIC BYSTOLIC
Common or Proper name BYSTOLIC 20MG TAB 30 CA BYSTOLIC 20MG TAB 30 CA
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients Nebivolol Nebivolol
Strength(s) 20.0MG 20.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size BYSTOLIC 20MG TAB 30 CA BYSTOLIC 20MG TAB 30 CA
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-05-24 2019-05-24
Actual start date 2019-05-24 2019-05-24
Estimated end date 2019-06-05 2019-06-05
Actual end date 2019-06-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Potential issue with the label Potential issue with the label
Health Canada comments